{"organizations": [], "uuid": "1841357a5af3f5d9883e107e2e456693c35c9f18", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180212.html", "section_title": "Archive News &amp; Video for Monday, 12 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sirenas-enters-into-multi-target-c/brief-sirenas-enters-into-multi-target-collaboration-with-bristol-myers-squibb-idUSFWN1Q211V", "country": "US", "domain_rank": 408, "title": "BRIEF-Sirenas Enters Into Multi-Target Collaboration With Bristol-Myers Squibb", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.077, "site_type": "news", "published": "2018-02-12T21:21:00.000+02:00", "replies_count": 0, "uuid": "1841357a5af3f5d9883e107e2e456693c35c9f18"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sirenas-enters-into-multi-target-c/brief-sirenas-enters-into-multi-target-collaboration-with-bristol-myers-squibb-idUSFWN1Q211V", "ord_in_thread": 0, "title": "BRIEF-Sirenas Enters Into Multi-Target Collaboration With Bristol-Myers Squibb", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 12 (Reuters) - Sirenas-\n* SIRENAS ENTERS INTO MULTI-TARGET COLLABORATION WITH BRISTOL-MYERS SQUIBB\n* ‍SIRENAS SAYS CO WILL RECEIVE AN UNDISCLOSED UP-FRONT PAYMENT, FUNDING FOR RESEARCH ACTIVITIES AND POTENTIAL SUCCESS FEES FROM BRISTOL-MYERS SQUIBB​\n* ‍BRISTOL-MYERS HAS OPTION TO LICENSE COMPOUNDS IDENTIFIED FROM COLLABORATIVE EFFORTS UNDER A SEPARATE AGREEMENT\n* ENTERED INTO AGREEMENT WITH BRISTOL-MYERS SQUIBB TO DEPLOY CO‘S DRUG DISCOVERY PLATFORM TO IDENTIFY POTENTIAL DRUG CANDIDATES Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-12T21:21:00.000+02:00", "crawled": "2018-02-13T15:33:56.004+02:00", "highlightTitle": ""}